Phase I pharmacological and bioavailability study of oral diflomotecan (BN80915), a novel E-ring-modified camptothecin analogue in adults with solid tumors

AJ Gelderblom; R Salazar; Jaap Verweij; G Pentheroudakis; Maja de Jonge; M Devlin; CMC Hooije; F Seguy; R Obach; J Prunonosa; P Principe; C Twelves

Phase I pharmacological and bioavailability study of oral diflomotecan (BN80915), a novel E-ring-modified camptothecin analogue in adults with solid tumors

AJ Gelderblom, R Salazar, Jaap Verweij, G Pentheroudakis, Maja de Jonge, M Devlin, CMC Hooije, F Seguy, R Obach, J Prunonosa, P Principe, C Twelves

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

44 Citations (Scopus)

1 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	4101-4107
Number of pages	7
Journal	Clinical Cancer Research
Volume	9
Publication status	Published - 2003

Access to Document

14519632.pdfFinal published version, 134 KB

http://hdl.handle.net/1765/10229

Cite this

Gelderblom, AJ., Salazar, R., Verweij, J., Pentheroudakis, G., de Jonge, M., Devlin, M., Hooije, CMC., Seguy, F., Obach, R., Prunonosa, J., Principe, P., & Twelves, C. (2003). Phase I pharmacological and bioavailability study of oral diflomotecan (BN80915), a novel E-ring-modified camptothecin analogue in adults with solid tumors. Clinical Cancer Research, 9, 4101-4107. http://hdl.handle.net/1765/10229

@article{1a6317c2c11e4f1cab4664f1269f3448,

title = "Phase I pharmacological and bioavailability study of oral diflomotecan (BN80915), a novel E-ring-modified camptothecin analogue in adults with solid tumors",

author = "AJ Gelderblom and R Salazar and Jaap Verweij and G Pentheroudakis and {de Jonge}, Maja and M Devlin and CMC Hooije and F Seguy and R Obach and J Prunonosa and P Principe and C Twelves",

year = "2003",

language = "Undefined/Unknown",

volume = "9",

pages = "4101--4107",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

}

Gelderblom, AJ, Salazar, R, Verweij, J, Pentheroudakis, G, de Jonge, M, Devlin, M, Hooije, CMC, Seguy, F, Obach, R, Prunonosa, J, Principe, P & Twelves, C 2003, 'Phase I pharmacological and bioavailability study of oral diflomotecan (BN80915), a novel E-ring-modified camptothecin analogue in adults with solid tumors', Clinical Cancer Research, vol. 9, pp. 4101-4107. <http://hdl.handle.net/1765/10229>

TY - JOUR

T1 - Phase I pharmacological and bioavailability study of oral diflomotecan (BN80915), a novel E-ring-modified camptothecin analogue in adults with solid tumors

AU - Gelderblom, AJ

AU - Salazar, R

AU - Verweij, Jaap

AU - Pentheroudakis, G

AU - de Jonge, Maja

AU - Devlin, M

AU - Hooije, CMC

AU - Seguy, F

AU - Obach, R

AU - Prunonosa, J

AU - Principe, P

AU - Twelves, C

PY - 2003

Y1 - 2003

M3 - Article

VL - 9

SP - 4101

EP - 4107

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

ER -